NO20026219L - Forbindelser for behandling av svekket fundisk relaksasjon - Google Patents

Forbindelser for behandling av svekket fundisk relaksasjon

Info

Publication number
NO20026219L
NO20026219L NO20026219A NO20026219A NO20026219L NO 20026219 L NO20026219 L NO 20026219L NO 20026219 A NO20026219 A NO 20026219A NO 20026219 A NO20026219 A NO 20026219A NO 20026219 L NO20026219 L NO 20026219L
Authority
NO
Norway
Prior art keywords
compounds
treatment
fundic relaxation
impaired fundic
impaired
Prior art date
Application number
NO20026219A
Other languages
English (en)
Other versions
NO20026219D0 (no
NO328547B1 (no
Inventor
Kristof Van Emelen
Marcel Frans Leopold De Bruyn
Manuel Jesus Alcazar-Vaca
Jose Ignacio Andres-Gil
Francisco Javi Fernandez-Gadea
Maria Enc Matesanz-Ballesteros
Jose Manuel Bartolome-Nebreda
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20026219D0 publication Critical patent/NO20026219D0/no
Publication of NO20026219L publication Critical patent/NO20026219L/no
Publication of NO328547B1 publication Critical patent/NO328547B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
NO20026219A 2000-06-22 2002-12-23 Forbindelser for behandling av svekket fundisk relaksasjon NO328547B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202180 2000-06-22
PCT/EP2001/006749 WO2001098306A1 (en) 2000-06-22 2001-06-13 Compounds for treating impaired fundic relaxation

Publications (3)

Publication Number Publication Date
NO20026219D0 NO20026219D0 (no) 2002-12-23
NO20026219L true NO20026219L (no) 2003-02-17
NO328547B1 NO328547B1 (no) 2010-03-15

Family

ID=8171674

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026219A NO328547B1 (no) 2000-06-22 2002-12-23 Forbindelser for behandling av svekket fundisk relaksasjon

Country Status (33)

Country Link
US (2) US7081453B2 (no)
EP (1) EP1296987B1 (no)
JP (1) JP4911860B2 (no)
KR (1) KR100821107B1 (no)
CN (2) CN100516066C (no)
AR (1) AR032158A1 (no)
AT (1) ATE312104T1 (no)
AU (1) AU783292B2 (no)
BG (1) BG65895B1 (no)
BR (1) BR0111859B1 (no)
CA (1) CA2410233C (no)
CZ (1) CZ305005B6 (no)
DE (1) DE60115647T2 (no)
EA (1) EA005760B1 (no)
EE (1) EE04878B1 (no)
EG (1) EG24462A (no)
ES (1) ES2254467T3 (no)
HR (1) HRP20020988B1 (no)
HU (1) HU227398B1 (no)
IL (2) IL153559A0 (no)
IS (1) IS2618B (no)
JO (1) JO2352B1 (no)
MX (1) MXPA02012844A (no)
MY (1) MY155267A (no)
NO (1) NO328547B1 (no)
NZ (1) NZ522519A (no)
PA (1) PA8519601A1 (no)
PL (1) PL201656B1 (no)
SA (1) SA01220442B1 (no)
SK (1) SK287730B6 (no)
UA (1) UA74576C2 (no)
WO (1) WO2001098306A1 (no)
ZA (1) ZA200210303B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100702526B1 (ko) 1999-06-02 2007-04-04 얀센 파마슈티카 엔.브이. 피롤리디닐, 피페리디닐 또는 호모피페리디닐 치환된(벤조디옥산, 벤조푸란 또는 벤조피란) 유도체
UA73122C2 (en) 1999-06-02 2005-06-15 Janssen Pharmaceutica Nv Derivatives of benzodioxane, benzofuran or benzopyran substituted by aminoalkyl
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
EP1622569B1 (en) 2003-04-24 2015-12-02 Incyte Corporation Aza spiro alkane derivatives as inhibitors of metallproteases
JP4896476B2 (ja) * 2005-09-16 2012-03-14 広栄化学工業株式会社 メチルオキシメチルアミノピリジン誘導体及びその製造方法
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
BRPI0811204A8 (pt) * 2007-05-10 2015-09-22 Bristol Myers Squibb Co Tetra-hidroibenzo-1,4-diazepinas substituídas por arila e heteroarila e uso das mesmas para bloquear a recaptação de norepinefrina, dopamina e serotonina
AU2012335220B2 (en) 2011-11-11 2017-06-01 Pfizer Inc. 2-thiopyrimidinones
SG11201708407TA (en) 2015-05-05 2017-11-29 Pfizer 2-thiopyrimidinones
CN105481839B (zh) * 2015-11-23 2018-05-11 安徽千和新材料科技发展有限公司 一种光活性环氧啉对映体的制备方法
EP3229193A1 (en) 2016-04-07 2017-10-11 The Boeing Company A computer-implemented method and system for sharing information between passengers and air traffic management stakeholders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
DE2400049A1 (de) * 1974-01-02 1975-07-10 Spumalit Anstalt Transportkasten aus kunststoff, insbesondere fuer flaschen
GR71865B (no) * 1978-03-20 1983-07-07 Ciba Geigy
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
EP0144101B1 (en) * 1983-11-30 1991-02-06 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines
SI9300097B (en) 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
ZA931343B (en) 1992-03-06 1993-09-24 Akzo Nv 1,4-dioxino(2,3-b)pyridine derivatives.
US6403103B1 (en) * 1994-08-12 2002-06-11 Bio Merieux Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease
FR2744451B1 (fr) 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
UA73122C2 (en) * 1999-06-02 2005-06-15 Janssen Pharmaceutica Nv Derivatives of benzodioxane, benzofuran or benzopyran substituted by aminoalkyl
KR100702526B1 (ko) * 1999-06-02 2007-04-04 얀센 파마슈티카 엔.브이. 피롤리디닐, 피페리디닐 또는 호모피페리디닐 치환된(벤조디옥산, 벤조푸란 또는 벤조피란) 유도체
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus

Also Published As

Publication number Publication date
HUP0301185A3 (en) 2009-03-30
PA8519601A1 (es) 2002-08-26
IL153559A (en) 2008-03-20
US20040019051A1 (en) 2004-01-29
HRP20020988B1 (en) 2011-06-30
EP1296987A1 (en) 2003-04-02
HK1057896A1 (en) 2004-04-23
EA005760B1 (ru) 2005-06-30
US7423048B2 (en) 2008-09-09
US20060142318A1 (en) 2006-06-29
KR20030007566A (ko) 2003-01-23
IS6591A (is) 2002-10-25
EP1296987B1 (en) 2005-12-07
WO2001098306A1 (en) 2001-12-27
CA2410233A1 (en) 2001-12-27
BG65895B1 (bg) 2010-04-30
PL201656B1 (pl) 2009-04-30
KR100821107B1 (ko) 2008-04-14
JP4911860B2 (ja) 2012-04-04
CZ2003115A3 (cs) 2003-06-18
NZ522519A (en) 2003-09-26
EG24462A (en) 2009-07-16
JP2004501157A (ja) 2004-01-15
SK287730B6 (en) 2011-07-06
BR0111859B1 (pt) 2015-01-06
EE200200694A (et) 2004-06-15
SK492003A3 (en) 2003-07-01
CN1288157C (zh) 2006-12-06
SA01220442B1 (ar) 2008-05-21
US7081453B2 (en) 2006-07-25
NO20026219D0 (no) 2002-12-23
EA200300049A1 (ru) 2003-04-24
JO2352B1 (en) 2006-12-12
CZ305005B6 (cs) 2015-03-25
AU783292B2 (en) 2005-10-13
ES2254467T3 (es) 2006-06-16
MY155267A (en) 2015-09-30
CN100516066C (zh) 2009-07-22
CA2410233C (en) 2011-01-25
BG107313A (bg) 2003-06-30
MXPA02012844A (es) 2003-05-15
IS2618B (is) 2010-04-15
ZA200210303B (en) 2004-03-19
ATE312104T1 (de) 2005-12-15
BR0111859A (pt) 2003-05-13
AR032158A1 (es) 2003-10-29
HUP0301185A2 (hu) 2003-08-28
PL358886A1 (en) 2004-08-23
HU227398B1 (hu) 2011-05-30
CN1781921A (zh) 2006-06-07
HRP20020988A2 (en) 2005-02-28
NO328547B1 (no) 2010-03-15
UA74576C2 (en) 2006-01-16
AU8386401A (en) 2002-01-02
IL153559A0 (en) 2003-07-06
DE60115647T2 (de) 2006-08-24
DE60115647D1 (de) 2006-01-12
EE04878B1 (et) 2007-08-15
CN1437602A (zh) 2003-08-20

Similar Documents

Publication Publication Date Title
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20031443L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20031442D0 (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
PL369895A1 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20024486L (no) Forbedret behandling av neovaskularisering
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
NO20033804D0 (no) Karbamatforbindelser for behandling av smerte
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
ATE312104T1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
NO20030717D0 (no) Forbindelser for behandling av avhengighetsforstyrrelser
NO20032769D0 (no) Kombinasjonsmetode for behandling av virale infeksjoner
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
NO20025765L (no) Kombinasjonssett for behandling av malaria
NO20042166L (no) Kombinasjonsterapi for behandling av sykdom
NO20011189D0 (no) Innretning for behandling av suspensjoner
ITMI20000147A0 (it) Procedimeto per il trattamento di fanghi
NO996166L (no) FremgangsmÕte for behandling av avluter

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees